O'Connor, Gemma <br/><br/>
Inhalable poly(lactic-co-glycolic acid) (PLGA) microparticles encapsulating all-trans-Retinoic acid (ATRA) as a host-directed, adjunctive treatment for Mycobacterium tuberculosis infection.  [electronic resource] 

 -  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V  Jan 2019 
 - 153-165 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-3441 
<br/><br/><label>Standard No.: </label>10.1016/j.ejpb.2018.10.020  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Animals<br/>Antitubercular Agents--administration & dosage<br/>Delayed-Action Preparations--administration & dosage<br/>Disease Models, Animal<br/>Drug Carriers--chemistry<br/>Drug Compounding--methods<br/>Drug Liberation<br/>Female<br/>Humans<br/>Macrophages, Alveolar--drug effects<br/>Mice<br/>Mice, Inbred BALB C<br/>Mycobacterium tuberculosis--drug effects<br/>Particle Size<br/>Polylactic Acid-Polyglycolic Acid Copolymer--chemistry<br/>Pulmonary Alveoli--drug effects<br/>THP-1 Cells<br/>Treatment Outcome<br/>Tretinoin--administration & dosage<br/>Tuberculosis, Pulmonary--drug therapy